COVID-19 Vaccines, Testing and Compensations

This document was uploaded by one of our users. The uploader already confirmed that they had the permission to publish it. If you are author/publisher or own the copyright of this documents, please report to us by using this DMCA report form.

Simply click on the Download Book button.

Yes, Book downloads on Ebookily are 100% Free.

Sometimes the book is free on Amazon As well, so go ahead and hit "Search on Amazon"

Over 450,000 Americans have died due to COVID-19 and the deaths continue to climb. We need to be making continuous improvements that will stop this virus. Chapter 1 examines ways to further expand testing, the use of therapeutics, and increasing vaccine confidence while prioritizing quick and efficient distribution of the vaccines. More than 200 million Americans have received one or more doses of a Coronavirus Disease 2019 (COVID-19) vaccine, along with billions of people worldwide. A very small percentage of inoculated individuals experience serious adverse reactions to a COVID-19 vaccine. Chapter 2 reviews the compensation programs available if a serious reaction does occur.

Author(s): Mark N. Frierson
Series: Infectious Diseases and Microbiology
Publisher: Nova Science Publishers
Year: 2022

Language: English
Pages: 314
City: New York

Contents
Preface
Chapter 1
Road to Recovery: Ramping up Covid-19 Vaccines, Testing, and Medical Supply Chain(
Opening Statement of Hon. Anna G. Eshoo, a Representative in Congress from the State of California
Prepared Statement of Hon. Anna G. Eshoo
Opening Statement of Hon. Brett Guthrie, a Representative in Congress from the Commonwealth of Kentucky
Prepared Statement of Hon. Brett Guthrie
Opening Statement of Hon. Frank Pallone, Jr., a Representative in Congress from the State of New Jersey
Prepared Statement of Hon. Frank Pallone, Jr.
Opening Statement of Hon. Cathy Mcmorris Rodgers, a Representative in Congress from the State of Washington
Prepared Statement of Hon. Cathy Mcmorris Rodgers
Supply Chain
Statements of Luciana Borio, M.D., Vice President, In-Q-Tel; Julie Morita, M.D., Executive Vice President, Robert Wood Johnson Foundation; Michael O. Leavitt, Founder and Chair, Leavitt Partners; and Greg Burel, President and Principal Consultant, Ha...
Statement of Luciana Borio, M.D.
Testimony of Luciana Borio, M.D., Vice-President, In-Q-Tel, “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021, Subcommittee on Health of the House Committee on Energy and Commerce
Introduction
The COVID-19 Pandemic
Past
Present
Vaccines
Variants
Therapies
Diagnostic Tests
Data Infrastructure
Supply Chain
Future
Conclusion
Statement of Julie Morita, M.D.
Hearing Testimony, Julie Morita, MD, Executive Vice President, Robert Wood Johnson Foundation, U.S. House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Me...
Equity
Accessibility
Coordination
Conclusion
Testimony Addendum, Julie Morita, MD, Executive Vice President, Robert Wood Johnson Foundation, U.S. House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and M...
Research
Anticipating COVID-19 Vaccination Challenges through Flu Vaccination Patterns
COVID-19 and the Experiences of Populations at Greater Risk
Ensuring Access to the COVID-19 Vaccine for Adult Medicaid Enrollees: A Roadmap for States
Ensuring Equity: State Strategies for Monitoring COVID-19 Vaccination Rates by Race and Other Priority Populations
For Most Workers, the Latest COVID-19 Vaccine Developments Won’t Mean Protection Just Yet
How Risk of Exposure to the Coronavirus at Work Varies by Race and Ethnicity and How to Protect the Health and Well-Being of Workers and Their Families
The Impact of Coronavirus on Households across America
Pandemics and Health Equity: Lessons Learned from the H1N1 Response in Los Angeles County
Preemption, Public Health, and Equity in the Time of COVID-19
Resources
Advancing Equity in the Nation’s COVID-19 Public Health Response and Recovery: Options for a New Administration
ASTHO Bounce Forward
Center for Strategic and International Studies Panel on Vaccine Confidence and Misinformation
COVID-19 Equitable Testing Strategy
Diversity Data Kids & The Child Opportunity Index
Language of Vaccine Acceptance Poll and Vaccine Communication Tips
National Immigration Law Center’s Resources Related to the COVID-19 Crisis and Consequences
US COVID Atlas
Opinion Pieces
America’s Last Line of Defense for a Safe Vaccine
Pressure Won’t Build Vaccine Trust
We Need a Vaccine Distribution Plan—Right Now
Statement of Michael Leavitt
U.S. House Energy and Commerce Health Subcommittee Hearing, “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021, Governor Michael O. Leavitt, Former U.S. Secretary of Health and Human Services, Salt La...
Pandemic Response Requires Strategically “Scouting the Next Valley”
Scouting the Next Valley for COVID-19 – Issues and Recommendations
Developing an Open-Source Vendor-Agnostic Digital Vaccination and Testing Credential
Strengthening Domestic Capacity to Rapidly Manufacture Vaccines after the Emergence of a Virus
Anticipating the Potential Needs of Patients with “Long-COVID”
Anticipating and Addressing the Barriers of Social Determinants of Health and Inequity
Resourcing and Sustaining Our Public Health Infrastructure
Resourcing and Sustaining Medical and Scientific Innovation
Strengthening Our Commitment to Mental Health
Responding to the Challenges that Pandemic Presents to Medicare’s Financing
Prioritizing Pandemic Preparedness on an Ongoing Basis
Assisting the Nation’s Governors in Strengthening Medicaid’s Response to the Pandemic
Learning Continually by Scouting Valleys Beyond
Conclusion
Statement of Greg Burel
Opening Statement of Greg Burel, Committee on Energy & Commerce, February 3, 2021
Article of January 31, 2021, “‘It’s a mess’: Biden’s first 10 days dominated by vaccine mysteries,” by Tyler Pager, Adam Cancryn and Joanne Keenen, Politico, Submitted by Ms. Eshoo
Biden Administration Readies Battle Plan as Covid Variants Reach the U.S.
Statement by the Association of American Medical Colleges on “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain” Submitted for the Record to the Energy and Commerce, Subcommittee on Health, United States House of Repres...
Ramping up COVID-19 Vaccines
Ramping up COVID-19 Testing
The Medical Supply Chain
Ramping up COVID-19 Vaccines
Ramping up COVID-19 Testing
The Medical Supply Chain
Conclusion
Statement of the National Immigration Law Center, House Committee on Energy and Commerce Subcommittee on Health, Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain, Tuesday February 3, 2021
Insufficient Funding for Community Focused Outreach and Assistance
States Are Not Allowed to Discriminate against Immigrants in Distribution
Everyone, Regardless of Their Immigration Status, Should Have Access to Free COVID-19 Testing, Vaccinations and Treatment
Protecting Sensitive Data and Addressing Privacy Concerns
Congress and the Administration Should Ensure That Language Access Is Prioritized and Protected
Front-Line Immigrant Workers Must Have Equitable Access to Vaccines
Immigrants Must Not Fear Immigration Consequences from Vaccination
Immigrants in Detention Must Have Equitable Access to Vaccines
Written Statement for the Record, for the Hearing Entitled “Road to Recovery: Ramping up Covid-19 Vaccines, Testing, and Medical Supply Chain,” United States House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, February...
COVID-19 National Crisis Is Disproportionately Impacting Communities of Color
Vaccine Distribution Must be Equitable
Essential Workers
Social Determinants of Health
Multi-Generational Homes
Language Access
Immigration Status
Detailed Demographic Data about Vaccine Administration Is Needed
Written Testimony of the American Psychological Association, by Arthur C. Evans, Jr, PhD, Chief Executive Officer and Executive Vice President American Psychological Association, Submitted to the Subcommittee on Health, of the Committee on Energy an...
Legislative Priorities in the 117th Congress
The Pathway to Recovery
Equity
Vaccines
Testing and Contact Tracing
Statement from the American Society for Microbiology, in Response to the House Energy & Commerce, Subcommittee on Health, Hearing: “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
Increase Testing Capacity and Access
Increase Transparency
Statement of Steven C. Anderson, President and Chief Executive Officer, The National Association of Chain Drug Stores (NACDS), for United States House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, on “Road to Recovery: ...
Executive Summary
Discussion
Accessible and Trusted Retail Pharmacies Are Boosting Critical Access to COVID-19 Vaccines and Testing in Communities across the Nation
Retail Pharmacies Play a Key Role In Expanding Access to COVID-19 Vaccines
Outside of Vaccinations, Retail Pharmacies Are Reshaping the Public Health Infrastructure to Provide Additional Services, Like COVID-19 Testing, to Patients on a Larger Scale
Recommendations to Ensure Retail Pharmacies Have the Authorities to Continue to Help Fight This Pandemic and Strengthen the Public Health Infrastructure Moving Forward
Recommendation 1: Maintain Important Authorities Established under the PREP Act Declaration, Which Have Expanded Patient Access to Vaccination and Testing Services at Local Retail Pharmacies
Recommendation 2: Sustain the Ability for Retail Pharmacies to Continue to Provide Vaccination, Testing, and Relevant Preventative Services by Establishing Clear Coverage and Reimbursement Pathways
Recommendation 3: Ensure Critical Patient Access to Pharmacy Services by Expanding the Federal Pharmacy Partnership Program to Serve Medicare and Medicaid Populations
Conclusion
Statement for the Record, American Nurses Association, Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain, House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, February 3, 2021
Medical Supply Chain
Vaccines
Vaccine Equity
Conclusion
Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021
Discussion
Acknowledgments
References
Written Testimony for the House Energy and Commerce Committee: Subcommittee on Health, “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
Lack of Capacity at Local and State Health Departments
About the National Health Care for the Homeless Council
Trump’s Operation Warp Speed Promised a Flood of Covid Vaccines. Instead, States Are Expecting a Trickle
U.S. CDC Says 41.4 Million Doses of COVID-19 Vaccines Distributed, 20.5 Million Administered
‘Pixie Dust’: Why Some Vaccine Sits on Shelves While Shortages Intensify Nationwide
Thousands of Vaccine Appointments Canceled as Supply Lags
ʻItʼs Such a Lotteryʼ: Disappointment and Frustration as Vaccine Offers Melt Away
On Bidenʼs First Day in Charge, Swift Action on Covid-19 and the Economy Is a Priority
Frustrations Boil at Pace of Vaccinations at Long-Term Care Facilities
Trump Officials Actively Lobbied to Deny States Money for Vaccine Rollout Last Fall
About the Author
Administration Leaves Testing Responsibility to States in Report to Congress
Itʼs Just Everywhere Alreadyʼ: How Delays in Testing Set Back the U.S. Coronavirus Response
A Prime Mission
Sense of Exasperation
ʻWhat Do We Do?ʼ
A Silent Spread
Months into Virus Crisis, U.S. Cities Still Lack Testing Capacity
Health Workers Still Face Shortages of Critical Medical Supplies
Sarah Mccammon, Host
Oxygen Supply Shortages Bedevil Hospitals Already Overwhelmed by COVID-19 Patients
Oxygen
California Coronavirus Hospitalizations
The Stories Shaping California
Warning of Shortages, Researchers Look to Stretch Vaccine Supply
President Biden Announces American Rescue Plan
Mount a National Vaccination Program, Contain COVID-19, and Safely Reopen Schools
Mount a National Vaccination Program
Scale up Testing to Stop the Spread of COVID, Safely Reopen Schools, and Protect at-Risk Populations
Mobilize a Public Health Jobs Program to Support COVID-19 Response
Address Health Disparities and COVID-19
Protect Vulnerable Populations in Congregate Settings
Identify and Address Emerging Strains of COVID-19
Provide Emergency Relief and Purchase Critical Supplies and Deploy National Guard
Invest in Treatments for COVID-19
Protect Workers against COVID-19
Restore U.S. Leadership Globally and Build Better Preparedness
Provide Schools the Resources They Need to Reopen Safely
Provide Emergency Paid Leave to 106 Million More Americans to Reduce the Spread of the Virus
Deliver Immediate, Direct Relief to Families Bearing the Brunt of the Crisis
Extend and Expand Unemployment Insurance Benefits so American Workers Can Pay Their Bills
President Biden’s plan will:
Help Struggling Households Keep a Roof over Their Heads
Address the Growing Hunger Crisis in America
Raise the Minimum Wage to $15 per Hour
Call on Employers to Meet Their Obligations to Frontline Essential Workers and Provide Back Hazard Pay
Expand Access to High-Quality, Affordable Child Care
Bolster financial Security for Families and Essential Workers in the Midst of the Pandemic
Preserving and Expanding Health Coverage
Expanding Access to Behavioral Health Services
Ensure Adequate Funding for Veterans’ Health
Combat Increased Risk of Gender-Based Violence
Provide Critical Support to Struggling Communities
President Biden’s plan will:
Provide Small Businesses with the Funding They Need to Reopen and Rebuild
Provide Support for first Responders and Other Essential Workers
Protect the Future of Public Transit
Support Tribal Governments’ Response to COVID-19
Modernize Federal Information Technology to Protect against Future Cyber Attacks
Executive Order on Ensuring a Data-Driven Response to COVID-19 and Future High-Consequence Public Health Threats
Section 1. Policy
Sec. 2. Enhancing Data Collection and Collaboration Capabilities for High-Consequence Public Health Threats, Such as the COVID-19 Pandemic
Sec. 3. Public Health Data Systems
Sec. 4. Advancing Innovation in Public Health Data and Analytics
Sec. 5. Privileged Information
Sec. 6. General Provisions
Executive Order on a Sustainable Public Health Supply Chain
Section 1. Purpose
Sec. 2. Immediate Inventory of Response Supplies and Identification of Emergency Needs
Sec. 3. Pricing
Sec. 4. Pandemic Supply Chain Resilience Strategy
Sec. 5. Access to Strategic National Stockpile
Sec. 6. General Provisions
Executive Order on Establishing the COVID-19 Pandemic Testing Board and Ensuring a Sustainable Public Health Workforce for COVID-19 and Other Biological Threats
Section 1. Policy
Sec. 2. COVID-19 Pandemic Testing Board
Sec. 3. Actions to Address the Cost of COVID-19 Testing
Sec. 4. Establishing a Public Health Workforce Program
Sec. 5. General Provisions
Biden Covid Team Derides Trump Plan While Borrowing Playbook
J&J Single-Dose Vaccine Provides Strong Shield against Covid
Partisan Rhetoric
Biden’s Approach
100-Day Pledge
No Good Vaccine Deed
Covid, Kids and Teachers Unions
Why Operation Warp Speed Worked
Will Biden Cut a Covid Deal with Republicans?
American Pharmaceutical Resilience
Global Supply Chains and Economic "Resilience": (More) Evidence from the Pandemic
Coronavirus: Operation Warp Speed Timeline
Jan. 12, 2021
Jan. 6, 2021
Dec. 30, 2020
Dec. 28, 2020
Dec. 23, 2020
Dec. 21, 2020
Dec. 19, 2020
Dec. 18, 2020
Dec. 16, 2020
Dec. 14, 2020
Dec. 12, 2020
Dec. 11, 2020
Nov. 24, 2020
Nov. 23, 2020
Nov. 21, 2020
Nov. 18, 2020
Nov. 12, 2020
Nov. 10, 2020
Nov. 9, 2020
Oct. 28, 2020
Oct. 23, 2020
Oct. 19, 2020
Oct. 16, 2020
Oct. 13, 2020
Oct. 9, 2020
Sept. 23, 2020
Sept. 16, 2020
Sept. 8, 2020
Sept. 3, 2020
Aug. 29, 2020
Aug. 28, 2020
Aug. 23, 2020
Aug. 17, 2020
Aug. 14, 2020
Aug. 13, 2020
Aug. 11, 2020
Aug. 5, 2020
Aug. 4, 2020
July 31, 2020
July 30, 2020
July 27, 2020
July 22, 2020
July 13, 2020
July 7, 2020
July 2, 2020
June 18, 2020
June 15, 2020
June 11, 2020
June 9, 2020
June 1, 2020
May 21, 2020
May 15, 2020
May 12, 2020
April 16, 2020
March 30, 2020
FAQs
Operation Warp Speed
Coronavirus: DOD Response
Operation Warp Speed Staffers Refute Claim Biden Is Starting from Scratch on Vaccines
Current and Former Staffers Say They Helped Set Biden’s Administration on a Glide Path to Its Vaccination Goal
Proud of Vaccine Success, Warp Speed’s Ex-Science Head Talks Politics, Presidents, and Future Pandemics
Statement for the Record, Submitted by the Premier Inc. Healthcare Alliance, Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain, House Energy and Commerce Subcommittee on Health, February 3, 2021
Premier’s Reflections & Learnings from COVID-19 Response Efforts
Strengthening the Healthcare Supply Chain to Address Future Pandemics
Incentivizing Domestic Manufacturing
Augmenting the Strategic National Stockpile
Solutions to Environmental Issues Impacting Patient Care
Maintaining Supply Chain Integrity
Expediting COVID-19 Vaccinations of the American People
#1 Vaccine Hesitancy
#2 Clinical Staffing Limitations
#3 Distribution Challenges
#4 Supply Shortages
#5 Communication Gaps
Creating Upstream and Downstream Visibility
Expanding Infection Prevention Clinical Surveillance
Conclusion
Attachment—Additional Questions for the Record, Subcommittee on Health, Hearing on “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
The Honorable Frank Pallone, Jr. (D-NJ)
The Honorable Lisa Blunt Rochester (D-DE)
The Honorable Brett Guthrie (R-KY)
The Honorable Michael C. Burgess, M.D. (R-TX)
The Honorable Neal P. Dunn, M.D. (R-FL)
Attachment—Additional Questions for the Record, Energy and Commerce, Subcommittee on Health, Hearing on “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
The Honorable Frank Pallone, Jr. (D-NJ)
Community vaccination sites are a critical part of the American Rescue Plan that has been proposed by the Biden Administration. Specifically, a $20 billion investment has been included to help set up these sites, some of which will be able to vaccinat...
During a public health emergency, one of the most important roles of the federal government is to provide clear, consistent, and fact-based communication. The CDC has played a key role in federal messaging during this pandemic by publishing guidelines...
How do you think CDC’s approach to communication throughout the last year has impacted the public’s willingness to be tested for COVID-19 and participate in local contact tracing efforts?
In what ways do you think CDC is succeeding in their approach to communicating about the COVID-19 vaccine and in what ways do you think they can improve?
The Honorable Michael C. Burgess, M.D. (R-TX)
The CDC’s Advisory Committee on Immunization Practices (ACIP) made its vaccine prioritization recommendations to assist jurisdictions in decision making on how to allocate the limited doses of available vaccines. The ACIP recommendations identify non-...
The current vaccine distribution chain only involves one distributor. Have there been capacity issues with distribution that could be solved by involving more private distribution companies? Are there certain areas, for example rural, that are more di...
The Honorable Gus Bilirakis (R-FL)
Obesity has proved to be a major risk factor in the COVID-19 pandemic and past pandemics, such as the H1N1 pandemic in 2019. Over 40% of Americans have obesity, and that number is projected to continue to grow. In addition to hampering our public heal...
Attachment—Additional Questions for the Record, Subcommittee on Health, Hearing on “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
The Honorable Frank Pallone, Jr. (D-NJ)
Governor Leavitt Response
The Honorable Nanette Diaz Barragán (D-CA)
Governor Leavitt Response
The Honorable Michael C. Burgess, M.D. (R-TX)
Governor Leavitt Response
Governor Leavitt Response
Governor Leavitt Response
The Honorable Brett Guthrie (R-KY)
Governor Leavitt Response
Governor Leavitt Response
Governor Leavitt Response
Governor Leavitt Response
Governor Leavitt Response
Governor Leavitt Response
The Honorable Gus M. Bilirakis (R-FL)
Governor Leavitt Response
Governor Leavitt Response
Attachment—Additional Questions for the Record, Subcommittee on Health, Hearing on “Road to Recovery: Ramping up COVID-19 Vaccines, Testing, and Medical Supply Chain,” February 3, 2021
The Honorable Frank Pallone, Jr. (D-NJ)
The Honorable Michael C. Burgess, M.D. (R-TX)
The Honorable Gus M. Bilirakis (R-FL)
The Honorable Billy Long (R-MO)
The Honorable Larry Bucshon, M.D. (R-IN)
Chapter 2
Compensation Programs for Potential COVID-19
Vaccine Injuries(
The Countermeasures Injury Compensation Program
Covered Vaccines and Injuries
Procedure for Obtaining Compensation
Available Compensation
The National Vaccine Injury Compensation Program
Covered Vaccines and Injuries
Procedure for Obtaining Compensation
Available Compensation
Considerations for Congress
Index
Blank Page